期刊文献+

UGRP1与甲状腺结节性质、功能及BRAF基因的相关性 被引量:5

Correlation between UGRP1 and the properties, functions and BRAF gene expression of thyroid nodules
下载PDF
导出
摘要 目的探讨甲状腺结节子宫球蛋白相关蛋白1(UGRP1)的表达与甲状腺结节性质、功能及BRAFV600E基因突变的关系。方法 153例甲状腺组织取自131例以甲状腺结节为主诉的患者,根据细针穿刺细胞学检查(US-FNAC)结果分为甲状腺结节组(47例)、桥本甲状腺炎组(38例)、甲状腺癌组(46例),正常甲状腺组(22例)取自良性结节旁正常甲状腺组织。通过免疫组化方法分析甲状腺细胞UGRP1的表达,分析4组患者UGRP1表达情况,UGRP1阳性组和阴性组甲状腺功能、超声特征以及与BRAFV600E基因突变的关系。结果桥本甲状腺炎、甲状腺结节和甲状腺癌组UGRP1阳性表达率分别为71.1%、4.3%和2.2%,正常甲状腺组织中UGRP1表达阴性,差异有统计学意义(P<0.05)。TT3、TT4、TSH在UGRP1阳性组和阴性组差异无统计学意义。UGRP1表达与BRAFV600E基因突变之间存在相关性(P=0.023,C=0.414)。结论甲状腺结节中,桥本甲状腺炎UGRP1阳性高表达,UGRP1可能作为区分桥本甲状腺炎与正常甲状腺和甲状腺癌的参考指标之一。 Objective To investigate the relationship between the expression of uteroglobin-related protein 1(UGRP1) in thyroid cells and the properties, functions and the mutation of BRAFV600E gene in patients of thyroid nodules.Methods According to the results of cytological examination, 153 cases of aspirated thyroid tissues from 131 patients with thyroid nodules as the chief complaints undergone thyroid fine needle aspiration cytology(FNAC) examinations, were divided into thyroid nodules group(47 cases), Hashimoto′s thyroiditis group(38 cases) and thyroid carcinoma group(46 cases). Thyroid tissues adjacent to benign nodules were classified as normal thyroid group( 22 cases). The expressions of UGRP1 in thyroid cells obtained by FNAC were detected by immunohistochemistry,and the expressions of UGRP1 in the four groups were analyzed,as well as the thyroid functions,ultrasonic characteristics,the relationship between UGRP1 expression and BRAFV600Egene mutation in the positive and negative UGRP1 expression groups. Results The positive UGRP1 expression rates in Hashimoto’ s thyroiditis group,thyroid nodules group and thyroid carcinoma group were 71. 1%,4. 3% and 2. 2% respectively. UGRP1 was negatively expressed in normal thyroid group. There was significant difference between the four groups( P <0. 05). There was no significant difference in TT3,TT4 and TSH between the positive and negative UGRP1 expression groups. There was a correlation between UGRP1 expression and BRAFV600E gene mutation( P = 0. 023,C =0. 414). Conclusion In thyroid nodules,Hashimoto’s thyroiditis was highly positive expression for UGRP1. The positive expression of UGRP1 may be one of the reference indexes to distinguish Hashimoto’s thyroiditis from normal thyroid and thyroid carcinoma.
作者 吴月 杜丹丹 官伟宁 左春林 Wu Yue;Du Dandan;Guan Weining(Dept of Endocrinology,The First Affiliated Hospital of Anhui Medical University,Hefei 230022;Dept of Oncologycells Chamber,The First Affiliated Hospital of Anhui Medical University,Hefei 230022)
出处 《安徽医科大学学报》 CAS 北大核心 2021年第5期802-806,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81270864)。
关键词 甲状腺结节 UGRP1 桥本甲状腺炎 甲状腺癌 BRAFV600E thyroid nodules uteroglobin-related protein 1 hashimoto′s thyroiditis thyroid carcinoma BRAFV600E
  • 相关文献

参考文献3

二级参考文献22

  • 1冯尚勇,刘超,刘晓云,段宇,刘翠萍.江苏高淳、楚州地区社区人群甲状腺结节流行特征研究[J].南京医科大学学报(自然科学版),2006,26(8):717-720. 被引量:66
  • 2Gomez Saez JM. Diagnostic and prognostic markers in differentiated thyroid cancer. Curr Genomics, 2011,12:597-608.
  • 3Kouniavsky G, Zeiger MA. The quest for diagnostic molecular markers for thyroid nodules with indeterminate ar suspicious cytology. J Surg Oncol, 2012,105:438-443.
  • 4Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol, 2011,5:51-56.
  • 5Marchetti I, Iervasi G, Mazzanti CM, et al. Detection of the BRAF (V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection : an easy tool to improve the preoperative diagnosis. Thyroid, 2012,22:292-298.
  • 6Nikiforov YE. Molecular analysis of thyroid tumors. Mod Pathol, 2011, 24 ( Suppl 2 ) : S34-S43.
  • 7Yu S, Liu Y, Wang J, et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab, 2012,97:2084-2092.
  • 8YaoZ, Yin P, Su D, et al. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Mol Biosyst, 2011,7 : 2608 -2614.
  • 9Fukahori M, Yoshida A, Hayashi H, et al. The association between RAS gene mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort. Thyroid, 2012. [Epub ahead of print].
  • 10Handkiewicz-Junak D, Czarniecka A, Jarzab B. Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions. Mol Cell Endocrinol, 2010,322:8-28.

共引文献270

同被引文献20

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部